It was first FDA-approved in 2010 under the brand name Egrifta for HIV-associated lipodystrophy, a condition causing excess visceral fat accumulation
In their marketing, telehealth companies claim that compounded GLP-1s in small doses starting lower than FDA-approved doses from Novo Nordisk and Eli Lilly can reduce metabolic risk, lower inflammatory markers, and even lower the risk of cognitive decline
Theyre trying to observe whether combining repair, remodeling, and inflammation-related inputs changes the overall pattern in a model
(Most glutathione 1000mg, glutathione 500mg, and liposomal glutathione products wont disclose their purity levels - higher purity means more active compound in every dose.) Each batch is produced using standardized processes to help support consistency and reliability from bottle to bottle
Some of the most popular drugs on the market are GLP-1 (glucagon-like peptide-1) agonists
Thats why we use natural sweeteners like stevia, allulose, and monk fruit instead as well as natural coloring and flavoring derived from fruits and other foods